Physician

Mazen Mislmani, M.D.

According to 2025 Medicare claims, Mazen Mislmani, M.D. (NPI: 1538489554) practices radiation oncology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is WEST MICHIGAN CANCER CENTER (NPI: 1588778484; TIN: 383061574) and primary practice location at 49007-3731.

Mislmani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 137 traditional Medicare patients, billed 2,949 HCPCS/CPT codes, and received $484,932 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 94 prescription claims across 51 beneficiaries totaling $1,882 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 1 records totaling $24. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $444 and ending at $1,882. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	43	955	$155,778
2016	147	3,438	$569,918
2017	227	4,414	$676,400
2018	272	5,171	$850,625
2019	250	4,362	$798,855
2020	275	4,247	$769,805
2021	202	3,399	$587,879
2022	188	4,152	$709,615
2023	138	2,945	$497,580
2024	137	2,949	$484,932

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	26	$444
2016	65	171	$3,749
2017	44	86	$1,539
2018	30	57	$1,377
2019	41	71	$1,892
2020	31	46	$1,133
2021	34	50	$1,261
2022	52	89	$2,314
2023	53	87	$1,942
2024	51	94	$1,882

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	67	769	$256
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	51	51	$161
77427	Radiation treatment management, 5 treatment sessions	50	210	$146
77014	Ct guidance for insertion of radiation therapy fields	78	825	$88
77336	Continuing radiation therapy consultation per week	56	201	$65

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Tamsulosin Hcl	Tamsulosin Hcl	54	4,560	$1,409

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$24	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mazen Mislmani, M.D.?

Tedicare shows public-source Medicare data for Mazen Mislmani, M.D. (NPI 1538489554), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mazen Mislmani, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mazen Mislmani, M.D.?

Mazen Mislmani, M.D. is linked to WEST MICHIGAN CANCER CENTER (billing NPI 1588778484) in the available physician profile data.

Does Mazen Mislmani, M.D. have Open Payments data?

Mazen Mislmani, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.